US 11826325
Use of Belinostat or pharmaceutically acceptable salt thereof in preparation of drug for treating infection
granted A61KA61K31/18A61P
Quick answer
US patent 11826325 (Use of Belinostat or pharmaceutically acceptable salt thereof in preparation of drug for treating infection) held by The First Affiliated Hospital of Xi'an Jiaotong University expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The First Affiliated Hospital of Xi'an Jiaotong University
- Grant date
- Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/18, A61P, A61P31/04